Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the ...

Kairos Investment Management Co. purchased the 1980s-era building at the end of 2023 for athird of its prior sale price.

Kairos Pharma shares were higher as the company reported positive safety results from a clinical trial of ENV-105, or carotuximab, in patients with metastatic castration-resistant prostate cancer.

Kairos Pharma Ltd (NYSE:KAPA) saw its stock jump 165% following the announcement of encouraging safety results from its ongoing Phase 2 clinical trial of ENV-105 in patients battling metastatic ...

Kairos Investment Management landed a $38.3 million senior loan from Harbor Group International (HGI) for 1250 I Street NW, a ...

Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharma company developing cancer therapies, announced favorable interim safety results from ...

Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces positive safety results from its ongoing Phase 2 ...

Like most open-world games, Borderlands 4 will have its fair share of collectibles to hunt down. The catch here is that ...

Investing.com -- Kairos Pharma Ltd (NYSE: KAPA) stock surged 165% after the clinical-stage biopharmaceutical company reported positive safety results from its ongoing Phase 2 clinical trial of ENV-105 ...

Kairos Ministry will honor 2025 college bound students, continuing college students, and area businesses during its 19th Annual Scholarship Awards and Honorees Banquet.

A new residential treatment home for young adults held its grand opening in Medford on Thursday. Operated by Kairos Northwest, the facility, called Sonata, is designed to be a healing space and marks ...